Top stories






Marketing & MediaBizTrends2027 | Theme launches | Steer year-defining business conversations
Bizcommunity.com 1 day
More news







Logistics & Transport
Why freight needs to move from visibility to intervention

Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.